mutation predictions | marginal predictions | summary statistics | genome diff | command line log
|
breseq version 0.33.1 revision 8505477f25b3
mutation predictions | marginal predictions | summary statistics | genome diff | command line log |
| Marginal read alignment evidence (highest frequency 20 of 56 shown, sorted by frequency from high to low) | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| seq id | position | ref | new | freq | score (cons/poly) | reads | annotation | genes | product | ||
| * | CP000730 | 76,295 | 0 | T | C | 64.2% | 226.7 / 222.1 | 234 | intergenic (+353/‑781) | USA300HOU_0072/USA300HOU_0075 | universal stress protein/lysophospholipase |
| * | CP000730 | 36,087 | 0 | A | G | 62.2% | 300.9 / inf | 327 | C155C (TGT→TGC) | tpn | IS431mec transposase |
| * | CP000730 | 36,124 | 0 | G | A | 61.5% | 145.2 / 281.9 | 239 | A143V (GCT→GTT) | tpn | IS431mec transposase |
| * | CP000730 | 76,322 | 0 | G | A | 60.4% | 140.6 / 270.2 | 230 | intergenic (+380/‑754) | USA300HOU_0072/USA300HOU_0075 | universal stress protein/lysophospholipase |
| * | CP000730 | 36,269 | 0 | C | T | 59.8% | 101.0 / inf | 334 | A95T (GCA→ACA) | tpn | IS431mec transposase |
| * | CP000730 | 36,315 | 0 | G | A | 58.4% | 115.7 / inf | 333 | Y79Y (TAC→TAT) | tpn | IS431mec transposase |
| * | CP000730 | 512,643 | 0 | A | G | 58.1% | 25.5 / 49.9 | 44 | intergenic (+711/‑150) | recR/rrs1 | recombination protein RecR/16S ribosomal RNA |
| * | CP000730 | 76,353 | 0 | G | A | 57.2% | 96.5 / 241.6 | 187 | intergenic (+411/‑723) | USA300HOU_0072/USA300HOU_0075 | universal stress protein/lysophospholipase |
| * | CP000730 | 35,970 | 0 | T | C | 54.1% | 122.5 / inf | 254 | E194E (GAA→GAG) | tpn | IS431mec transposase |
| * | CP000730 | 36,413 | 0 | C | T | 53.9% | 10.5 / 224.9 | 154 | V47I (GTC→ATC) | tpn | IS431mec transposase |
| * | CP000730 | 1,929,872 | 0 | G | A | 53.7% | 4.5 / 96.8 | 67 | intergenic (‑955/‑213) | USA300HOU_1794/USA300HOU_1796 | hypothetical protein/hypothetical protein |
| * | CP000730 | 1,929,873 | 0 | C | A | 53.7% | 8.2 / 120.0 | 67 | intergenic (‑956/‑212) | USA300HOU_1794/USA300HOU_1796 | hypothetical protein/hypothetical protein |
| * | CP000730 | 1,929,875 | 0 | T | C | 53.7% | 26.8 / 86.3 | 67 | intergenic (‑958/‑210) | USA300HOU_1794/USA300HOU_1796 | hypothetical protein/hypothetical protein |
| * | CP000730 | 1,929,867 | 0 | G | T | 52.9% | 1.4 / 113.1 | 68 | intergenic (‑950/‑218) | USA300HOU_1794/USA300HOU_1796 | hypothetical protein/hypothetical protein |
| * | CP000730 | 1,929,870 | 0 | A | C | 52.9% | 51.8 / 85.0 | 68 | intergenic (‑953/‑215) | USA300HOU_1794/USA300HOU_1796 | hypothetical protein/hypothetical protein |
| * | CP000730 | 35,876 | 0 | C | T | 52.2% | 30.5 / 68.3 | 46 | intergenic (+107/+1) | rlmH/tpn | hypothetical protein/IS431mec transposase |
| * | CP000730 | 1,929,842 | 0 | T | . | 51.4% | 141.1 / 179.2 | 70 | intergenic (‑925/‑243) | USA300HOU_1794/USA300HOU_1796 | hypothetical protein/hypothetical protein |
| * | CP000730 | 1,929,843 | 0 | A | . | 51.4% | 135.0 / 177.5 | 70 | intergenic (‑926/‑242) | USA300HOU_1794/USA300HOU_1796 | hypothetical protein/hypothetical protein |
| * | CP000730 | 1,929,848 | 0 | C | A | 51.4% | 21.6 / 129.7 | 70 | intergenic (‑931/‑237) | USA300HOU_1794/USA300HOU_1796 | hypothetical protein/hypothetical protein |
| * | CP000730 | 1,929,861 | 0 | T | C | 51.4% | 12.7 / 96.2 | 70 | intergenic (‑944/‑224) | USA300HOU_1794/USA300HOU_1796 | hypothetical protein/hypothetical protein |